DL-AP5 Sodium saltCat No.
3693
|
Price and Availability |
|
Chemical Name: DL-2-Amino-5-phosphonopentanoic acid sodium salt |
|
Biological Activity
Sodium salt of DL-AP5 (Cat. No. 0105). Potent NMDA antagonist.Technical Data
M.Wt:The technical data provided above is for guidance only.
For batch specific data refer to the Certificate of Analysis and MSDS.
Resources
Certificate of Analysis / MSDS
References
Evans et al (1982) The effect of a series of w-phosphonic-a-carboxylic amino acids on electrically evoked and amino acid induced responses in isolated spinal cord preparations. Br.J.Pharmacol. 75 65. Davies and Watkins (1982) Actions of D and L forms of 2-amino-5-phosphonovalerate and 2-amino-4-phosphonobutyrate in the cat spinal cord. Brain Res. 235 378.If you know of a useful citation for this product please let us know.
Keywords: DL-AP5 Sodium salt, Broad, spectrum, EAA, antagonists, Glutamate, Ionotropic, Non-Selective, iGluR, Receptors, mGlur, Metabotropic
Buy Now / Print Quote
Find multiple products by catalog number
Print Quote Facility
Order via your purchasing department
It's now even easier to place orders via your purchasing department.
Simply add a product to your cart & click on the "Print Quote" button.
Antidepressants - Current and Future Targets
Written by P. Skolnich et al
'Antidepressants - Current and Future Targets' provides an overview of the current and future targets for the treatment of major depressive disorder.
Calcium Imbalance and Neuroprotective Targets
Written by E. Besancon et al
'Calcium Imbalance and Neuro-protective Targets in Cerebral Ischemia & Brain Injury' highlights the key targets involved in stroke, trauma and neurodegeneration.
Modulators of Peripheral Sensitization
Written by M.R. Vasko and G.D. Nicol
'Pharmacological Modulators of Peripheral Sensitization' summarizes the inhibitory and excitatory modulators of peripheral sensitization.
Neurobiology of Parkinson's Disease
Written by A. Schapira
'Neurobiology and Therapeutics of Parkinson's Disease' highlights the neurobiology of Parkinson's disease and highlights current and novel therapeutic interventions.
New Products in this Area
Sodium salt of kynurenic acid (Cat. No. 0223)
DL-AP5 Sodium saltSodium salt of DL-AP5 (Cat. No. 0105)
Pep2m, myristoylatedMyristoylated form of pep2m. Peptide inhibitor of GluR2 subunit binding to NSF
TheanineGlutamate receptor ligand
RSS News Feed
Find out about new products as soon as they go live!
Click on the orange RSS button to read more about our RSS feed and actively opt in.